×
For best experience we recommend to activate Javascript in your browser.
LAIR1 antibody (AA 22-163)
This Rabbit Polyclonal antibody specifically detects LAIR1 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for LAIR1 antibody (AA 22-163) (ABIN7621582)
Target
See all LAIR1 Antibodies
LAIR1
(Leukocyte-Associated Immunoglobulin-Like Receptor 1 (LAIR1))
Reactivity
All reactivities for LAIR1 antibodies
Human
Host
All hosts for LAIR1 antibodies
Rabbit
Clonality
All clonalities for LAIR1 antibodies
Polyclonal
Conjugate
All conjugates for LAIR1 antibodies
This LAIR1 antibody is un-conjugated
Application
All applications for LAIR1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-LAIR1 Antibody
(hide)
Binding Specificity
All epitopes for LAIR1 antibodies
AA 22-163
Purpose
Leukocyte Associated Immunoglobulin Like Receptor 1 (LAIR1) Polyclonal Antibody
Sequence
Gln22~His163
Characteristics
The Leukocyte Associated Immunoglobulin Like Receptor 1 (LAIR1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for LAIR1
(hide)
Target
LAIR1
(Leukocyte-Associated Immunoglobulin-Like Receptor 1 (LAIR1))
Alternative Name
LAIR1
Gene ID
3903
UniProt
Q6GTX8
Recently viewed
(hide)
Chat with us , powered by LiveChat